Moderate-intensity statin therapy. Efficacy and safety issues
High rates of cardiovascular (CV) morbidity and mortality dictates the need to determine approaches to therapy that would reduce complications rate and improve patient’s prognosis. High-intensity statin therapy is an integral part of the treatment of patients with high and very high cardiovascular r...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2023-07-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5485 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849341393139400704 |
|---|---|
| author | N. G. Gogolashvili |
| author_facet | N. G. Gogolashvili |
| author_sort | N. G. Gogolashvili |
| collection | DOAJ |
| description | High rates of cardiovascular (CV) morbidity and mortality dictates the need to determine approaches to therapy that would reduce complications rate and improve patient’s prognosis. High-intensity statin therapy is an integral part of the treatment of patients with high and very high cardiovascular risk. At the same time, there is a large cohort of patients who would benefit from moderate intensity statin therapy. In the present article we have summarized available data on hypolipidemic effects, pleiotropic effects and role of moderate intensity statin therapy, atorvastatin particularly, in reding the risk of major adverse cardiac events. |
| format | Article |
| id | doaj-art-df1e87886b4e491bb0f46e134bdc7b2f |
| institution | Kabale University |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2023-07-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-df1e87886b4e491bb0f46e134bdc7b2f2025-08-20T03:43:37Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-07-0128610.15829/1560-4071-2023-54853848Moderate-intensity statin therapy. Efficacy and safety issuesN. G. Gogolashvili0Research Institute of Medical Problems of the North — Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; V.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityHigh rates of cardiovascular (CV) morbidity and mortality dictates the need to determine approaches to therapy that would reduce complications rate and improve patient’s prognosis. High-intensity statin therapy is an integral part of the treatment of patients with high and very high cardiovascular risk. At the same time, there is a large cohort of patients who would benefit from moderate intensity statin therapy. In the present article we have summarized available data on hypolipidemic effects, pleiotropic effects and role of moderate intensity statin therapy, atorvastatin particularly, in reding the risk of major adverse cardiac events.https://russjcardiol.elpub.ru/jour/article/view/5485statin therapylipid profilepleiotropic effects |
| spellingShingle | N. G. Gogolashvili Moderate-intensity statin therapy. Efficacy and safety issues Российский кардиологический журнал statin therapy lipid profile pleiotropic effects |
| title | Moderate-intensity statin therapy. Efficacy and safety issues |
| title_full | Moderate-intensity statin therapy. Efficacy and safety issues |
| title_fullStr | Moderate-intensity statin therapy. Efficacy and safety issues |
| title_full_unstemmed | Moderate-intensity statin therapy. Efficacy and safety issues |
| title_short | Moderate-intensity statin therapy. Efficacy and safety issues |
| title_sort | moderate intensity statin therapy efficacy and safety issues |
| topic | statin therapy lipid profile pleiotropic effects |
| url | https://russjcardiol.elpub.ru/jour/article/view/5485 |
| work_keys_str_mv | AT nggogolashvili moderateintensitystatintherapyefficacyandsafetyissues |